{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:57:20Z","timestamp":1792270640237,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neo.2024.101113","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T19:04:01Z","timestamp":1734807841000},"page":"101113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-2293","authenticated-orcid":false,"given":"Sheng-Kai","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-3470","authenticated-orcid":false,"given":"Wei-Yu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yuan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-0733","authenticated-orcid":false,"given":"Chia-Lin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Gin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Feng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun-Che","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Heng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2024.101113_bib0001","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0002","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0003","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jtho.2019.01.007","article-title":"Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in ALK-rearranged NSCLC","volume":"14","author":"Zheng","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0004","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jtho.2018.05.033","article-title":"Prolonged leptomeningeal responses with brigatinib in two heavily pretreated ALK-rearranged non-small cell lung cancer patients","volume":"13","author":"Geraud","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0005","article-title":"Phase II study of lorlatinib in patients with anaplastic lymphoma kinase-positive lung cancer and CNS-specific relapse","volume":"6","author":"Dagogo-Jack","year":"2022","journal-title":"JCo Precis. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12916-021-02207-x","article-title":"Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study","volume":"20","author":"Zou","year":"2022","journal-title":"BMC. Med."},{"key":"10.1016\/j.neo.2024.101113_bib0007","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.19.00457","article-title":"Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: The BLOOM Study","volume":"38","author":"Yang","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102557","article-title":"Acquired resistance mechanisms to osimertinib: The constant battle","volume":"116","author":"Zalaquett","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.neo.2024.101113_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0294-2020","article-title":"Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer","volume":"30","author":"Abdayem","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.neo.2024.101113_bib0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdy009","article-title":"Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy","volume":"29","author":"Li","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0011","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jmoldx.2021.03.001","article-title":"Clinical experience of cerebrospinal fluid-based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling","volume":"23","author":"Bale","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.neo.2024.101113_bib0012","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12916-022-02387-0","article-title":"Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases","volume":"20","author":"Zheng","year":"2022","journal-title":"BMC. Med."},{"key":"10.1016\/j.neo.2024.101113_bib0013","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0014","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3892\/ol.2016.4783","article-title":"Intrathecal chemotherapy as a treatment for leptomeningeal metastasis of non-small cell lung cancer: A pooled analysis","volume":"12","author":"Wu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.neo.2024.101113_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2019.05.019","article-title":"Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations","volume":"133","author":"Liang","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.neo.2024.101113_bib0016","first-page":"484","article-title":"Leptomeningeal metastases: a RANO proposal for response criteria","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0017","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jtho.2021.04.018","volume":"16","author":"Fan","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0018","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41416-022-01837-z","article-title":"Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment","volume":"127","author":"Kim","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2024.101113_bib0019","first-page":"15","article-title":"Practical utility of liquid biopsies for evaluating genomic alterations in castration-resistant prostate cancer","author":"Jeong","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2024.101113_bib0020","first-page":"15","article-title":"Accurate detection of urothelial bladder cancer using targeted deep sequencing of urine DNA","author":"Lee","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2024.101113_bib0021","doi-asserted-by":"crossref","first-page":"843","DOI":"10.7150\/ijbs.24626","article-title":"GeneFuse: detection and visualization of target gene fusions from DNA sequencing data","volume":"14","author":"Chen","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neo.2024.101113_bib0022","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gkz067","article-title":"Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA","volume":"47","author":"Gawronski","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.neo.2024.101113_bib0023","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.101113_bib0024","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-018-1936-6","article-title":"Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA","volume":"137","author":"Pan","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neo.2024.101113_bib0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/neuonc\/noz208","article-title":"A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer","volume":"22","author":"Nevel","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20040","article-title":"Detection of leptomeningeal disease using cell-free DNA from cerebrospinal fluid","volume":"4","author":"White","year":"2021","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.neo.2024.101113_bib0027","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0028","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2018.4305","article-title":"Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer","volume":"5","author":"Aggarwal","year":"2019","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0029","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jtho.2018.03.018","article-title":"Recurrently mutated genes differ between leptomeningeal and solid lung cancer brain metastases","volume":"13","author":"Li","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12885-019-5348-3","article-title":"Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases","volume":"19","author":"Ge","year":"2019","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.neo.2024.101113_bib0031","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-17-3555","article-title":"Identification of novel pathways of osimertinib disposition and potential implications for the outcome of lung cancer therapy","volume":"24","author":"MacLeod","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.101113_bib0032","doi-asserted-by":"crossref","first-page":"re6","DOI":"10.1126\/scisignal.2004652","article-title":"Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer","volume":"6","author":"Niederst","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neo.2024.101113_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920937953","article-title":"Intrathecal pemetrexed combined with involved-field radiotherapy as a first-line intra-CSF therapy for leptomeningeal metastases from solid tumors: a phase I\/II study","volume":"12","author":"Pan","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0034","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221078429","article-title":"A retrospective study of intrathecal pemetrexed combined with systemic therapy for leptomeningeal metastasis of lung cancer","volume":"21","author":"Geng","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.neo.2024.101113_bib0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jtho.2022.10.015","article-title":"MET alterations in NSCLC-current perspectives and future challenges","volume":"18","author":"Remon","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0036","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1200\/JCO.2022.40.16_suppl.9121","article-title":"Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)","volume":"40","author":"LP-A","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0037","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1200\/JCO.2023.41.16_suppl.9021","article-title":"Tepotinib + osimertinib for EGFR mutant (EGFRm) NSCLC with MET amplification (METamp) after first-line (1L) osimertinib","volume":"41","author":"TMK","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0038","article-title":"Heterogeneity and coexistence of T790M and T790 wild-type resistant subclones drive mixed response to third-generation epidermal growth factor receptor inhibitors in lung cancer","volume":"2018","author":"Piotrowska","year":"2018","journal-title":"J. Co Precis. Oncol."},{"key":"10.1016\/j.neo.2024.101113_bib0039","doi-asserted-by":"crossref","first-page":"11815","DOI":"10.1038\/ncomms11815","article-title":"Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients","volume":"7","author":"Chabon","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.101113_bib0040","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-021-22057-8","article-title":"Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers","volume":"12","author":"Vaclova","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T08:45:44Z","timestamp":1741077944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":40,"alternative-id":["S1476558624001544"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101113","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101113"}}